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Abstract
Calphostin C (cal-C) is a photoactivatable inhibitor that binds to the regulatory domain of protein kinase C (PKC) and
to other proteins that contain diacylglycerol/phorbol ester binding sites. Cal-C is cytotoxic against many types of
cancer cells, yet the basis for this activity remains poorly understood. Here, we show that one of the earliest ef-
fects of cal-C is an impairment of glycoprotein export from the endoplasmic reticulum (ER), accompanied by for-
mation of ER-derived vacuoles. Vacuolization of the ER is correlated with induction of an ER stress response that
includes activation of c-Jun N-terminal kinase and protein kinase R-like ER kinase, as well as increased expression
of CCAAT/enhancer binding protein homologous transcription factor (CHOP; GADD153). These effects of cal-C are
not mimicked by staurosporine, an inhibitor of PKC catalytic activity, indicating that ER stress is due to interaction
of cal-C with targets other than PKC. In conjunction with the induction of ER stress, breast carcinoma cells undergo
caspase-dependent cell death with early activation of caspases 9 and 7 and cleavage of poly(ADP-ribose)polymer-
ase. Reduction of CHOP expression by short hairpin RNA decreases the sensitivity of the cells to cal-C, suggesting
that induction of apoptosis by cal-C is related, at least in part, to ER stress triggered by disruption of ER morphol-
ogy and transport function. Antineoplastic drugs that work by inducting ER stress have shown promise in preclin-
ical and clinical trials. Thus, the present findings raise the possibility that cal-C may be useful for photodynamic
therapy based on induction of ER stress in some forms of cancer.
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Introduction
Protein kinase C (PKC) isozymes have been implicated as regulators
of signaling pathways that promote proliferation, survival, metastasis,
and drug resistance in cancer cells [1,2]. Elevated levels of PKC expres-
sion or activity have been noted in human malignancies such as glio-
mas [3], breast tumors [4], and metastatic gastric carcinoma [5]. Many
investigations have explored the antineoplastic activity of PKC in-
hibitors, with particular emphasis on the indocarbazoles (e.g., stauro-
sporine (STS)), which target the ATP binding site of PKC, and the
macrocyclic lactones (e.g., bryostatin 1), which antagonize PKC activa-
tion and stimulate ubiquitin-mediated degradation [1,6]. Despite en-
couraging preclinical results, the efficacy of these compounds in clinical
trials has been disappointing, possibly because of the number of func-
tionally distinct PKC isozymes and the lack of kinase specificity [7].
The fungal perylenequinone, calphostin C (cal-C), was initially de-
scribed as a potent inhibitor of PKC that operates through a novelmecha-
nism, binding to a Ca2+-induced hydrophobic site on the PKC
regulatory domain and preventing activation by diacylglycerol (DAG)
and phorbol esters [8,9]. The inhibitory activity of cal-C is strictly
dependent on photoexcitation, which causes irreversible site-specific
oxidative modification of PKC [10,11]. This has raised the prospect
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that cal-C might be a useful agent for photodynamic cancer therapy
[12]. Thus far, the evaluation of cal-C has been limited to preclin-
ical studies. The results have established that this inhibitor can in-
duce apoptosis in a broad spectrum of human cancer cell lines,
including glioma [13–15], cervical carcinoma [16], lymphoblastic
leukemia [17], prostate cancer [18], and nasopharyngeal carcinoma
[12]. However, important questions about the molecular mecha-
nisms underlying the cytotoxicity of cal-C remain to be answered.
In particular, accumulating evidence suggests that the compound
could operate through mechanisms that are independent of PKC.
For example, cal-C can directly inhibit phospholipase D [19], and
at concentrations that trigger apoptosis, it can cause a general in-
crease in reactive oxygen species (ROS) [16], oxidation and degra-
dation of lamin B1 [16], disassembly of Golgi membranes [20,21],
inhibition of endocytosis [21], and mobilization of calcium from
intracellular stores [17]. Further complicating matters, a study of
the effects of cal-C in wild type and drug-resistant MCF-7 breast
cancer cells indicated that the inhibitor can kill the cells by a novel
mechanism involving the accumulation of cytoplasmic vacuoles of
unknown origin [22]. In the present study, we have clarified the lat-
ter mechanism of calphostin-induced cell death by showing that the
cytoplasmic vacuoles arise from the endoplasmic reticulum (ER) and
that cell death is preceded by disruption of ER to Golgi trafficking
and induction of a robust ER stress response. These findings suggest
that cal-C may merit further evaluation as a potential photodynamic
agent that could be used to inhibit tumor progression by stimulating
ER stress.
Materials and Methods
Cell Culture and Transfection
MCF-7 breast carcinoma cells were a gift from A. Parissenti, North-
eastern Ontario Regional Cancer Centre. U251 glioblastoma cells were
from theDCTTumor Repository (National Cancer Institute, Bethesda,
MD). 501 MEL cells were from the Cell Culture Core Facility at
the Yale Skin Disease Research Center. All other cell lines were from
the American Type Culture Collection (Rockville, MD). Cells were
cultured at 37°C in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% fetal bovine serum with a 5% CO2 atmo-
sphere. The pDsRed2-ERmammalian expression vector was purchased
from Clontech (Palo Alto, CA). The vector encodes the ER targeting
sequence of calreticulin and an ER retention signal (KDEL) fused to
the red fluorescent protein. MCF-7 cells were transfected using the
FuGENEHD transfection reagent (Roche, Indianapolis, IN) according
to the manufacturer’s protocol. Phase-contrast images and fluorescent
images of DsRed-ER distribution in live cells were obtained using an
Olympus IX70 inverted microscope (Olympus America, Inc., Center
Valley, PA) equipped with a digital camera and SPOT imaging software
(Diagnostic Instruments, Inc, Sterling Heights, MI).
Generation of CCAAT/Enhancer Binding Protein Homologous
Transcription Factor Knockdown MCF-7 Cells
CCAAT/Enhancer Binding Protein Homologous Transcription
Factor (CHOP; GADD153) short hairpin RNA (shRNA) and control
(scrambled) shRNA lentiviral particles were purchased from Santa
Cruz Biotechnology (Santa Cruz, CA). MCF-7 cells were infected
with lentiviral particles as per the manufacturer’s protocol. The trans-
duced cells were selected in medium containing 1 μg/ml puromycin
for a week. Cells remaining after the selection were pooled and main-
tained continuously in medium containing puromycin for all subse-
quent experiments.
Drug Treatments and Photoactivation of Cal-C
Calphostin C (Tocris, Ellisville, MO) was dissolved in dimethyl-
sulfoxide (DMSO). Cells were preincubated in medium containing
cal-C in the dark at 37°C for 30 minutes, followed by exposure to
a 30-W fluorescent light at 3 inches from the source for another
30 minutes to activate cal-C. Time points indicated in the figures
start after the light was switched off. Control dishes were incubated
with an equivalent volume of DMSO under the same conditions.
During cotreatments, cal-C and z-VAD-fmk (Bachem Bioscience,
Inc, King of Prussia, PA) or z-LEVD-fmk (BioVision, Inc, Mountain
View, CA) were added simultaneously to the medium. The cultures
were then preincubated at 37°C for 1 hour, followed by photoactiva-
tion of cal-C, as described previously. In some experiments, cells were
treated with 500 nM STS (Cayman Chemical Company, Ann Arbor,
MI) or 2.5 μM brefeldin A (Sigma, St Louis, MO) as noted in the
figure legends.
Cell Viability
Cell viability was assessed using the 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT)–based cell growth determi-
nation kit from Sigma following the manufacturer’s protocol. The
MTT assays were performed in quadruplicate wells of a 96-well plate
24 hours after photoactivation of cal-C. The absorbance at 570 nm
was measured with a SpectraMax Plus plate reader (Molecular Devices,
Sunnyvale, CA). Statistical significance of differences between wells
treated with a specific drug concentration compared with the control
wells was assessed by Student’s t test. Half-maximal inhibitory concen-
tration (IC50) values for cal-C in different cell lines were determined
by performing MTT assays on cells exposed to drug concentrations of
0, 1, 5, 10, 25, 50,100, and 150 nM for 24 hours. IC50 values were
calculated from linear regression analysis of sigmoidal dose-response
curves plotted with GraphPad Prism software (La Jolla, CA).
For colony-forming assays, cells were harvested 24 hours after treat-
ment with 50 nM cal-C or DMSO. Attached cells were harvested by
trypsinization, pooled with the detached cells, counted, and replated in
100-mm-diameter dishes. MCF-7 and PANC-1 cells were seeded at
1600 cells per dish, and U251 cells were plated at 1400 cells per dish.
The medium was replaced every 3 to 4 days. Colonies were stained
and counted after 2 weeks for U251 cells and 3 weeks for MCF-7
and PANC-1 cells, as described [23].
Western Blot Analysis
The following antibodies used for Western blot analysis were pur-
chased: c-Jun N-terminal kinase (JNK), phospho-JNK, caspase 7, and
caspase 9 (Cell Signaling Technology, Danvers, MA); protein kinase
R-like ER kinase (PERK), phospho-PERK and CHOP (Santa Cruz
Biotechnology); poly(ADP-ribose)polymerase (PARP; BDPharmingen,
San Jose, CA); caspase 4 (MBL International, Woburn, MA); and
α-tubulin (Sigma). The BX6 antibody against the β-amyloid pre-
cursor protein (β-APP) was a gift from Elan Pharmaceuticals (South
San Francisco, CA). Cells were lysed directly in SDS sample buffer
[24], and protein concentrations were determined using the Bio-Rad
colorimetric assay (Bio-Rad Laboratories, Hercules, CA). Aliquots of
lysate containing equal amounts of protein were subjected to SDS-
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PAGE and immunoblot analysis using the procedures for chemi-
luminescence detection described previously [25]. Chemiluminescence
signals were quantified using an imaging system (FluorChem HD2;
Alpha Innotech, San Leandro, CA).
Annexin V Assay
Attached cells were harvested by trypsinization and pooled with
any detached cells in the medium. The cells were then stained with
the Guava Nexin reagent (Guava Technologies, Hayward, CA) con-
taining premixed annexin V–PE and 7-amino-actinomycin D fol-
lowing the manufacturer’s protocol. Annexin V–positive cells were
quantified by flow cytometry using a Guava Personal Cytometer.
Metabolic Labeling and Immunoprecipitation of β-APP
MCF-7 cells were washed twice with methionine-free DMEM and
incubated with either 50 nM cal-C or DMSO in methionine-free
DMEM, first for 30 minutes in the dark at 37°C and then exposed
to a 30-W fluorescent light source for 30 minutes. For pulse labeling,
100 μCi/ml [35S] methionine/cysteine mix (Easy Tag EXPRESS;
NEN/Perkin Elmer, Waltham, MA) was added to the cultures, and
cells were incubated at 37°C for 30 minutes. The “pulse” samples
were harvested immediately. Parallel cultures (the “chase” samples)
were washed with PBS and incubated in DMEM containing 10%
fetal bovine serum, 200 μM methionine, and 200 μM cysteine, with
or without cal-C. The cultures were exposed to light for 30 minutes
after addition of the chase medium containing fresh cal-C and then
incubated at 37°C for 1.5 hours (2 hours of total chase period). Cells
were harvested and lysed in PBS containing 1.0% Triton X-100 and
protease inhibitor cocktail (Roche), and radiolabeled β-APP was im-
munoprecipitated as described previously [26], using the anti-BX6
polyclonal antibody [27]. Immune complexes were collected by in-
cubation for 1 hour at 4°C with protein A-Sepharose (Amersham
Biosciences, Uppsala, Sweden) coupled to goat anti–rabbit immuno-
globulin G (MP Biomedicals, Inc, Solon, OH). Immunoprecipitated
proteins were subjected to SDS-PAGE and fluorography as described
[26]. The relative amounts of mature and immature β-APP were deter-
mined by densitometry using a Kodak 440CF image station (Eastman
Kodak Co, Rochester, NY).
Fluorescence Microscopy
MCF-7 cells were grown on glass coverslips for 24 hours and treated
with 50 nM cal-C or DMSO as described previously. Two hours after
cal-C treatment, cells were washed with Hank’s balanced salt solu-
tion, fixed in ice-cold methanol for 10 minutes, and blocked with
10% goat serum in PBS. For visualization of the Golgi apparatus, cells
were incubated for 1 hour with the anti-GM130 antibody (BD Trans-
duction Laboratories, San Jose, CA) diluted in PBS + 10% goat serum,
followed by incubation with goat anti–mouse immunoglobulin G
conjugated with Alexa Fluor 568 (Molecular Probes/Invitrogen,
Eugene, OR). Images were obtained using an Olympus IX70 fluores-
cence microscope equipped with a digital camera. Merger of phase-
contrast and fluorescent images was accomplished with the SPOT
imaging software.
For visualization of acidic lysosomal or late endosomal compart-
ments, cells were incubated with LysoTracker RedDND-99 (Invitrogen
Corp, Carlsbad, CA) as described previously [23], and live cell imaging
was performed as described previously for DsRed.
Statistical Analysis
All data are expressed as mean ± SD. Results were analyzed with
Student’s t test for unpaired samples using the GraphPad Prism soft-
ware. P ≤ .05 was considered as statistically significant.
Results
Cytoplasmic Vacuolization Precedes Loss of Viability in Tumor
Cell Lines Treated with Activated Cal-C
Exposure of MCF-7 breast carcinoma cells to photoactivated cal-C
in the concentration range of 15 to 100 nM caused a significant re-
duction in cell viability within 24 hours as determined by the MTT
cytotoxicity assay (Figure 1A). The effects of cal-C on cell viability
were confirmed by colony-forming assays (Figure 1B). Loss of viabil-
ity was accompanied by increased cleavage of the caspase substrate,
PARP, which was detectable as early as 2 hours after termination of
the light activation of cal-C (Figure 1C ). The 85-kDa PARP fragment
was identical in size to that generated in cells treated with STS, a
known PKC inhibitor and a potent inducer of apoptosis (Figure 1D).
As reported previously [22], death of the MCF-7 cells treated with
cal-C was preceded by extensive cytoplasmic vacuolization (Figure 2A).
We were able to detect the accumulation of phase-lucent vacuoles
within 1 to 3 hours after activation of cal-C. If the photoactivation
of cal-C was omitted, vacuoles did not form, and there was no increase
in cell death (Figure 2B). Shortly after the onset of vacuolization, some
of the cells began to detach from the surface of the culture dish, so that
by 24 hours, more than half of the cells in the culture were float-
ing. Examination of PARP cleavage in the detached versus attached cell
populations (Figure 1E) indicated that most of the floating cells were
undergoing cell death. Unlike the cells treated with cal-C, MCF-7 cells
treated with STS rounded and detached from the dish but did not
undergo vacuolization (Figure 2B).
To determine whether early cytoplasmic vacuolization is a general
characteristic of cal-C treatment in other types of cancer cells, we ex-
posed U251 glioblastoma and PANC-1 pancreatic carcinoma cells to
similar concentrations of the compound. In both cases, vacuoles accu-
mulated within 3 hours (Figure 2A), with substantial loss of cell via-
bility (Figure 1, A and B) and increased cleavage of PARP (Figure 1, D
and E) occurring by 24 hours. A broader survey of established cancer
cell lines indicated that cal-C generally induced substantial cytotoxicity
within 24 hours, with IC50 values ranging from 15 to 37 nM (Table 1).
Most of the adherent cell lines exhibited extensive vacuolization, but a
few did not (e.g., SW480, SKOV3).
Cytoplasmic Vacuoles Are Derived from the ER
The close temporal correlation between the onset of cytoplasmic
vacuolization (Figure 2A) and PARP cleavage (Figure 1C ) prompted
us to conduct further studies with MCF-7 cells to establish the origin
of the vacuoles induced by cal-C. Phase-lucent vacuoles can arise
from various subcellular compartments. For example, inhibition of
the class III phosphatidylinositol-3-kinase, Vps34, causes swelling
and vacuolization of late endosomes [28,29], whereas accretion of
misfolded proteins in cells treated with inhibitors of Hsp90 and the
ubiquitin-proteasome pathway causes distension of the ER [30]. Most
recently, we described a novel cell death pathway in which cells are
disrupted by the accumulation of large fluid-filled vacuoles derived
from macropinosomes [23].
To test the hypothesis that the vacuoles induced by cal-C are derived
from the ER, we transfected MCF-7 cells with a vector encoding a red
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fluorescent protein (DsRed) that contains specific ER targeting and
retention sequences. In nontreated MCF-7 cells, the marker was lo-
calized diffusely in the perinuclear region, a pattern typical for the
ER (Figure 3A). However, within 3 hours after light activation of
cal-C, the DsRed-ER was concentrated in discrete globular structures
that matched the lucent vacuoles observed by phase-contrast mi-
croscopy (Figure 3A). In contrast to these results, the phase-lucent
vacuoles induced by cal-C did not incorporate the late endosome/
lysosome tracer, LysoTracker Red (Figure 3B). Moreover, these struc-
tures did not internalize detectable quantities of fluid-phase tracers
such as Lucifer yellow or Dextran–Alexa Fluor 488 (not shown).
Essentially identical results were obtained when the studies were
performed with U251 and PANC-1 cells. These findings support
the conclusion that the cytoplasmic vacuoles induced by cal-C are
formed by dilation of ER cisternae.
Induction of Vacuoles by Cal-C Is Accompanied by ER Stress
In light of the known association between accumulation of unfolded
proteins and swelling of the ER, we undertook a series of studies with
MCF-7 cells to determine whether cal-C induces a prototypical ER
stress response concurrent with vacuolization. One of the earliest sign-
posts of ER stress is the phosphorylation of the stress-activated kinase,
JNK. JNK activation seems to be mediated through a signaling cas-
cade triggered by inositol-requiring enzyme 1 (IRE1), an ER resident
kinase/endoribonuclease that senses accumulation of misfolded pro-
teins [31,32]. As shown in Figure 4A, treatment of MCF-7 cells with
cal-C caused a spike in JNK phosphorylation that was maximal at
15 minutes to 1 hour. The level of JNK phosphorylation tapered off
slightly after 1 hour, consistent with a report that cells respond to
unmitigated ER stress by first activating and then attenuating IRE1
and JNK [32].
A second major branch of the ER stress response involves the ac-
tivation of PERK, a transmembrane protein kinase. PERK is phos-
phorylated in response to ER stress, resulting in the activation of its
cytoplasmic kinase domain, which targets eukaryotic initiation factor
2α and attenuates translation [33]. Activation of PERK is sustained
with prolonged ER stress [32]. Figure 4B shows that within 15 min-
utes after activation of cal-C, phosphorylation of PERK was increased
to approximately twice the level seen under baseline culture conditions
and remained elevated for the duration of the 4-hour experiment.
The preceding studies were extended by examining the expression
of CHOP (GADD153), a bZIP transcription factor that is upregu-
lated during the ER stress response [34] and is implicated in apoptosis
Figure 1. Cal-C reduces cell viability and induces PARP cleavage in
multiple tumor cell lines. (A) Cells were treated with the indicated
concentrations of cal-C (light-activated) and viability was assessed
24 hours later by MTT assay. Control cells (0 nM) were incubated
with a volume of DMSO equal to that added in the cultures that
received 100 nM cal-C. Each bar represents the mean (± SD) ob-
tained from quadruplicate wells of a 96-well plate. The decreases
observed at all cal-C concentrations for all cell lines were signifi-
cant at P ≤ .01 relative to the corresponding controls without drug.
(B) Each cell line was treated with 50 nM cal-C or an equal volume
of DMSO. Twenty-four hours after treatment, cells were harvested
and plated for the colony-forming assay, as described in the Mate-
rials and Methods section. Each bar represents the mean (± SD)
number of colonies colonies obtained from four separate cultures.
For each cell line, the decrease in the number of colonies after
treatment with cal-C compared with the DMSO-treated cells, was
significant at P ≤ .0001. (C) Immunoblots showing cleavage of
the caspase substrate, PARP, in MCF-7 cells treated with 50 nM
cal-C and harvested at the indicated time points. Tubulin served
as control to demonstrate comparable loading of protein in each
lane. (D) Cultures of MCF-7, U251, and PANC-1 cells were treated
with 50 nM cal-C for 18 hours. Parallel cultures were treated with
500 nM STS for 18 hours. Attached and detached cells were pooled
for immunoblot analysis of PARP. (E) Cells were treated with cal-C
as in panel D except that the attached (Att) and detached (Det) cells
were collected separately before immunoblot analysis for PARP.
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caused by ER stress [35]. As shown in Figure 5A, treatment of MCF-7
cells with cal-C caused a substantial increase in CHOP commencing
around 2 hours, coinciding with the timing of cytoplasmic vacuoliza-
tion and the first detectable increase in PARP cleavage (Figure 1C ). In
contrast to the robust increase in CHOP triggered by cal-C, STS,
which targets the catalytic domain of PKC, did not increase the expres-
sion of CHOP, even after 18 hours (Figure 5A). To determine whether
induction of CHOP was required for subsequent death of the cells
treated with cal-C, we used a lentiviral vector to introduce shRNA di-
rected against CHOP into MCF-7 cells. As shown by the Western
blots in Figure 5B, the induction of CHOP was reduced by approxi-
mately 70% when these cells were treated with cal-C for 24 hours.
Parallel cytotoxicity assays indicated that suppression of CHOP expres-
sion was able to partially protect the cal-C–treated cells from the loss of
cell viability (Figure 5C).
Death of Calphostin-Treated Cells Is Caspase-Dependent
The close temporal correlation between ER vacuolization, induc-
tion of ER-stress markers, and onset of PARP cleavage in MCF-7 cells
treated with cal-C suggests that, contrary to a previous report [22], cell
death is mediated by a caspase-dependent apoptotic pathway. To
directly test the importance of caspase activation in the death of
cal-C–treated MCF-7 cells, we added the broad-spectrum caspase in-
hibitor, z-VAD-fmk together with 50 nM activated cal-C for 24 hours.
As shown in Figure 6 (A and B), z-VAD effectively inhibited the
cleavage of PARP and significantly increased cell survival. Similar re-
sults were obtained with U251 and PANC-1 cells and with a separate
MCF-7 cell line obtained directly from the American Type Culture
Collection (not shown).
Independent evidence that the cal-C–treated MCF-7 cells were
undergoing apoptosis was obtained by staining them with the apop-
tosis marker, annexin V. Cal-C caused an increase in the percentage
of annexin V–positive MCF-7 cells, similar to what was observed in
cultures treated with STS (Figure 6C ).
Cal-C has been reported to induce rapid activation of mitochon-
drial death pathways and cleavage of procaspase 3 in several cell lines
[36,37]. Separate studies have implicated the mitochondrial apop-
tosome and caspase 3 as important mediators of ER stress–induced
apoptosis [38,39]. Consistent with these reports, we observed sub-
stantial activation of the mitochondrial initiator caspase, caspase 9,
within 1 hour after photoactivation of cal-C (Figure 7A). This co-
incided with the initial appearance of vacuoles (Figure 2A) and the
early spike in JNK and PERK phosphorylation (Figure 4, A and B).
By comparison, STS, which targets the catalytic site of PKC but does
not cause ER vacuolization or ER stress, did not begin to cause pro-
caspase 9 cleavage until 2 hours (Figure 7A).
Figure 2. Calphostin induces early accumulation of cytoplasmic vacu-
oles in multiple tumor cell lines. (A) MCF-7 and PANC-1 cells were
treated with 50 nM cal-C. U251 cells were treated with 30 nM
cal-C. Parallel control dishes were incubated with vehicle (DMSO).
(B) MCF-7 cells were incubated with 50 nM cal-C, 500 nM STS, or
DMSO (control) for 3 hours, with or without a 30-minute light activa-
tion step. Phase-contrast images (original magnification, ×400) of
live cells were obtained after 3 hours.
Table 1. IC50 Determined for Cal-C in Various Cell Lines.
Cell Line Vacuolization IC50 (nM)
MCF-7 (breast carcinoma) + 16.7
ZR-75 (breast carcinoma) + 31.9
U251 (glioblastoma) + 16.4
T98G (glioblastoma) + 26.6
501 MEL (melanoma) + 12.9
U20S (osteosarcoma) + 18.4
PANC-1 (pancreatic carcinoma) + 24.9
SW480 (colon carcinoma) − 14.7
SKOV3 (ovarian carcinoma) − 37.1
CaOV3 (ovarian carcinoma) − 29.8
Each cell line was treated with graded concentrations of cal-C for 24 hours, and the IC50 was
calculated from the results of the MTT assay. Separate cultures of each cell line were treated with
cal-C at concentrations of 30 to 50 nM and observed by phase-contrast microscopy after 3 hours to
determine whether cytoplasmic vacuolization occurred.
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Because MCF-7 cells lack the executioner caspase, caspase 3, we ex-
amined the activation of caspase 7. The latter is widely viewed as an
alternative executioner caspase that can act downstream from caspase 9
[40,41], but it has also been implicated as an initiator caspase in the
ER [42]. As shown in Figure 7B, the time course of procaspase 7 cleav-
age after treatment with cal-C closely matched that observed for pro-
caspase 9 (Figure 7A).
Finally, we examined the effects of cal-C on caspase 4. Some studies
have pointed to a role for caspase 4 in ER stress–induced cell death
[43,44], whereas others have argued that caspase 4 is not required
[45]. We observed an increase in procaspase 4 cleavage by 24 hours
after addition of cal-C, although the increase was not as great as that
seen with brefeldin A, a commonly used inducer of the ER stress re-
sponse (Figure 7C). However, we did not find a consistent increase in
cleavage of procaspase 4 above baseline levels during the critical early
period (1-4 hours) when ER vacuolization and ER stress markers were
induced (Figure 7C ). In agreement with these observations, the in-
hibitor, z-LEVD-fmk, used at a concentration reported to specifically
Figure 3. Vacuoles induced by cal-C are derived from the ER. (A)
MCF-7 cells were transfected with the pDsRed2-ER vector as de-
scribed in the Materials and Methods section. Twenty-four hours
after transfection, the cells were treated with 50 nM cal-C or DMSO
(control). Live-cell phase-contrast images and fluorescent images
showing the localization of the DsRed-ER protein (original magnifi-
cation, ×400) were obtained 3 hours after activation of cal-C. (B) Un-
transfected MCF-7 cells were treated with cal-C as in panel A, and
cells were incubated with LysoTracker Red for 1 hour before phase-
contrast microscopy and fluorescence imaging. Figure 4. Cal-C treatment induces an ER stress response concurrent
with ER vacuolization. (A) MCF-7 cells were harvested at the indi-
cated times after treatment with 50 nM cal-C, and equal amounts
of protein were subjected to immunoblot analysis for phospho-
JNK (Thr183/Tyr185) or total JNK. Tubulin served as a loading control.
The ratio of phospho to total proteins was determined by quantifying
the immunoblot signals with the FluorChem HD2 imaging system
(Alpha Innotech). The upper panel depicts a representative immuno-
blot of phospho-JNK and total JNK. The bar graph shows the mean
(± SD) of the ratio of phospho-JNK to total JNK determined from
three cultures. Asterisks denote values that were significantly in-
creased relative to the 0-hour time point (P ≤ .01). (B) Immunoblot
showing the time course of PERK (Thr981) phosphorylation after
treatment with cal-C. The ratios of phospho-PERK to total PERK
(mean ± SD) determined from three cultures are shown in the bar
graph. Asterisks denote values that were significantly increased rela-
tive to the 0-hour time point (P ≤ .02).
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block caspase 4 [46,47], failed to protect MCF-7 cells from cal-C–
induced cell death (Figure 7D).
Protein Trafficking between the ER and Golgi Compartment Is
Blocked by Cal-C
The observation that ER vacuolization and stress were caused by
cal-C, but not STS, suggested that the induction of ER stress could
be due to PKC-independent effects of cal-C. In this regard, our atten-
tion was drawn to an early study showing that cal-C, used at concen-
trations similar to those used in the present study, can block export
of proteins from the ER in a PKC-independent manner [48]. At sig-
nificantly higher concentrations (>500 nM), cal-C can also cause dis-
assembly of the Golgi apparatus [20,48]. To determine whether the
swelling of the ER observed within 1 to 2 hours after adding cal-C might
reflect an underlying inhibition of protein export from the ER, we took
advantage of the fact that MCF-7 cells, like most other cultured cell
lines, express measurable amounts of the Alzheimer β-amyloid precursor
protein (β-APP). The latter has been used as an endogenous tracer to
detect perturbations in vesicular trafficking of proteins from the ER to
the Golgi compartment [26,49].
β-APP is a type 1 transmembrane glycoprotein that exhibits an in-
crease in its apparent molecular mass on SDS gels after it is exported
from the ER and enters the Golgi apparatus. The mobility shift is due
to O-glycosylation of the exodomain [27,50]. The modified protein is
Figure 5. Cal-C induces expression of CHOP, and suppression of
CHOP blunts the cytotoxicity of cal-C. (A) Upper panel: Immuno-
blot showing the time course for induction of CHOP after treatment
with 50 nM cal-C. Lower panel: Immunoblot showing that CHOP is
not induced after treatment with 500 nM STS. Lysate from MCF-7
cells treated with cal-C for 4 hours served as a positive control for
CHOP expression in the last lane of the immunoblot. α-Tubulin was
used as the loading control. (B) Immunoblot showing that shRNA
blocks the induction of CHOP in MCF-7 cells treated with 25 nM
cal-C for 24 hours. CHOP expression was reduced by 70% relative
to the cal-C–treated cells expressing scrambled shRNA. Tubulin
served as a loading control. (C) MCF-7 cells expressing CHOP
shRNA or the control shRNA were cultured with or without 25 nM
cal-C for 24 hours. At the end point, the MTT values for four wells
treated with cal-C were expressed as percent of the mean value for
four wells without cal-C. The 33% increase in viability conferred
by blocking the induction of CHOP was significant at P = .0004.
Similar results were obtained in two separate experiments.
Figure 6. Cell death caused by cal-C in MCF-7 cells is caspase-
dependent. (A) MCF-7 cells were treated with 50 nM cal-C and/
or 50 μM z-VAD-fmk for 18 hours. Attached and detached cells
were pooled for immunoblot analysis of PARP. (B) MCF-7 cells
were treated with 50 nM cal-C and/or 50 μM z-VAD-fmk. Parallel
cultures treated with DMSO served as controls. Viability assays
were performed 24 hours after addition of the compounds. Each
bar represents the mean (± SD) of determinations performed on
four separate wells in a 96-well plate. The increase in viability of
the cells treated with cal-C plus z-VAD compared with cal-C alone
was significant at P = .001. (C) MCF-7 cells were incubated with
50 nM cal-C, 500 nM STS, or DMSO for 18 hours. Attached and
the detached cells were pooled and stained with the Guava Nexin
reagent. Annexin V–positive cells were analyzed using a Guava
Personal Cytometer. Each bar represents the mean (± SD) of de-
terminations performed on three separate cultures. The increases in
annexin-positive cells with STS or cal-C were significant at P ≤ .01.
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then further processed by endoproteases (α- or β-secretases) that cleave
off the glycosylated exodomain, which is secreted as soluble APP.
Subsequent proteolytic events catalyzed by γ-secretases can result in
the formation of amyloid β peptides from the residual C-terminal
membrane–anchored remnant of the protein [51]. To determine
whether cal-C causes an early block in export of β-APP from the ER,
we performed a pulse-chase study depicted in Figure 8. After a 30-minute
pulse with 35S-methionine, the radiolabeled β-APP immunoprecipitated
from control cells migrated predominantly as the immature (approxi-
mately 115 kDa) ER resident form, with a lesser amount of β-APP
migrating as the mature Golgi form (approximately 135 kDa; Fig-
ure 8A, left panel ). A similar distribution was observed for β-APP
when cal-C was included during the 30-minute pulse, although there
was a decrease in overall 35S-methionine incorporation into β-APP,
possibly because of a decline in the rate of protein synthesis. The
key observation is that when the cells were chased in the absence
of 35S-methionine for an additional 2 hours to allow time for the
immature β-APP to be exported to the Golgi apparatus, a significant
impairment of β-APP maturation was noted in cells treated with
cal-C compared with the controls (Figure 8A, right panel ). In the
control cells, the movement of the labeled β-APP into the Golgi
compartment was manifested by a marked decrease in intensity of
the radiolabeled immature band, so that the ratio of mature to im-
mature β-APP increased significantly (Figure 8B). In contrast, the
immature ER form of β-APP remained the predominant species in
the cells exposed to cal-C (Figure 8A, right panel ), and the ratio of
the mature Golgi to the immature ER form at the end of the chase
was essentially unchanged compared with the ratio at the end of the
30-minute pulse (Figure 8B). These findings are similar to what hap-
pens to processing of newly synthesized β-APP when cells express a
dominant-negative form of the Rab1b GTPase, which regulates ve-
sicular trafficking between the ER and Golgi compartments [26].
Western blot analyses of the steady state levels of β-APP in control-
versus cal-C–treated cells were consistent with the results of the pulse-
chase experiment (Figure 8C). During the first 30 minutes, the total
amounts of mature and immature forms of β-APP in cells treated with
cal-C were modestly reduced compared with the controls, but both
forms were readily detected. However, by 2 hours after activation of
cal-C, there was a notable loss of the mature form of β-APP. This is
exactly what one would expect if the preexisting pool of mature β-APP
continues to be proteolytically processed and secreted, whereas the
block in ER export of immature β-APP prevents replenishment of
the mature β-APP pool.
Taken together, the results of the preceding studies indicate that
cal-C causes a rapid arrest of ER → Golgi protein trafficking in
MCF-7 cells. To determine whether this could be related to the ef-
fects of cal-C on integrity of the Golgi stack, we performed immuno-
fluorescence localization of the Golgi marker, GM130. This revealed a
similar perinuclear Golgi staining pattern in both control- and cal-C–
treated cells (Figure 8D). Some cells exhibited a discrete juxtanuclear
cluster of GM130, whereas others showed a more dispersed staining
pattern. However, the distended ER-derived vacuoles in the cal-C–
treated cells were not stained with anti-GM130, suggesting that the
Golgi stack did not collapse into the ER. This implies that the observed
block in ER → Golgi trafficking of β-APP is most likely related to
functional impairment of the vesicular transport mechanism, rather
than complete disruption of the Golgi architecture, which has been
reported to occur at much higher cal-C concentrations [20,21,48].
Discussion
The present study provides several new insights into the previously
reported anticancer activity of the photoactivatable perylenequinone,
cal-C. First, we show that the tendency of cal-C to cause rapid cyto-
plasmic vacuolization, initially reported only in breast cancer cells
[22], extends to several other cancer cell lines and thus represents a
general characteristic of this compound. Second, we establish that the
vacuoles induced by cal-C arise from dilated ER cisternae. Third, we
Figure 7. Cal-C induces early activation of caspases 9 and 7 but not
caspase 4. MCF-7 cells were harvested at the indicated times after
activation of 50 nM cal-C. At each time point, attached and detached
cells were pooled, and equal amounts of protein were subjected to
immunoblot analysis for the indicated caspases. (A) Upper panel:
Time course of procaspase 9 cleavage to active 37- and 35-kDa frag-
ments in cal-C–treated MCF-7 cells. Lower panel: Time course of
procaspase 9 cleavage after treatment with STS. (B) Time course of
procaspase 7 cleavage after cal-C activation. (C) Time course of pro-
caspase 4 cleavage after treatment with cal-C. The separate lanes
at the right show procaspase 4 cleavage in MCF-7 cells that were
treated with 2.5 μM brefeldin A for 24 hours. (D) MCF-7 cells were
treated with cal-C alone or in combination with 20 μM z-LEVD-fmk
(caspase 4 inhibitor), as described in the Materials and Methods
section. MTT assays were performed after 24 hours. Each bar repre-
sents the mean (± SD) of determinations performed on four sepa-
rate wells in a 96-well plate.
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show that early vacuolization of the ER is accompanied by a per-
turbation of ER→ Golgi protein trafficking and a concurrent induc-
tion of the ER stress response. Finally, we demonstrate a very close
temporal correlation between ER vacuolization, induction of the
stress response, and the early onset of caspase-dependent apoptosis.
On the basis of these observations, we suggest a mechanism to ex-
plain the potent cytotoxic effects of cal-C in neoplastic cells. Specifi-
cally, we postulate that cal-C initially inhibits proteins with phorbol
ester/DAG binding sites that control vesicular trafficking out of the
ER. The resulting block in protein and membrane export leads to the
distention of the ER and to the accumulation of misfolded or aggre-
gated proteins, which trigger an ER stress response. Unabated ER
stress, probably compounded by additional effects of cal-C related to
inhibition of PKC, finally results in activation of a caspase-mediated
apoptotic death pathway.
In the original report describing cal-C–mediated vacuolization and
killing of parental and drug-resistant MCF-7 cell lines, cleavage of
PARP and mitochondrial cytochrome c release were not observed, sug-
gesting a nonapoptotic mechanism of cell death [22]. However, in
our studies, we clearly observed PARP cleavage, caspase activation,
increased staining with annexin V, and protection with z-VAD. One
possible explanation for this discrepancy may lie in the methods used
for harvesting the cells. In our studies, all of the PARP and caspase
assays were done with pooled attached and floating cells to avoid
losing detached cells that accounted for most of the apoptotic popula-
tion (Figure 1E). Our findings agree with numerous reports indicat-
ing that cal-C triggers caspase-dependent apoptosis in other types of
cells [12,13,17,36].
Our observation that STS, a potent inhibitor of PKC, did not stimu-
late ER vacuolization or induction of CHOP expression strongly sug-
gests that the initial effects of cal-C on ER function are related to the
interaction with targets other than PKC. One possibility, raised by the
work of Sciorra et al. [19], is that the effects of cal-C on protein export
are due to binding to the catalytic domain of phospholipase D1, a
known regulator of ER → Golgi trafficking [52]. An alternative pos-
sibility is that the effects of cal-C could be mediated by disruption of
calcium homeostasis. For example, in acute lymphoblastic leukemia
cells, the cytotoxic effect of cal-C correlates with rapid calcium mobi-
lization from intracellular stores and seems to be independent from
inhibition of PKC [17]. A third possibility, suggested by the early work
of Fabbri et al. [48], is that cal-C disrupts vesicular protein export from
the ER through the interaction with novel DAG/phorbol ester-binding
Figure 8. Export of an endogenous type I membrane glycopro-
tein (β-APP) from the ER is impaired in MCF-7 cells treated with
cal-C. Control- and cal-C–treated MCF-7 cells were labeled with
[35S]methionine for 30 minutes. One dish from each condition was
harvested immediately (pulse), and the other set was chased
for 2 hours in medium containing excess unlabeled methionine.
β-APP was immunoprecipitated as described in the Materials and
Methods section. (A) The pulse and chase samples were run on
separate gels and subjected to fluorography. The images are rep-
resentative of results obtained from three separate cultures. (B)
The bar graph shows the densitometric ratio of mature (135 kDa)
to immature (115 kDa) β-APP determined in the pulse and chase
samples. The results are expressed as mean (± SD) determined
from three separate cultures. The asterisk denotes a significant
increase at P = .01. (C) Western blot showing total mature and
immature β-APP. Cells maintained with or without 50 nM cal-C
were harvested 30 minutes or 2 hours after light activation. Equal
amounts of the whole-cell lysates were subjected to immunoblot
analysis for β-APP with tubulin as a loading control. (D) MCF-7 cells
were incubated with cal-C or DMSO for 2 hours after light activa-
tion and then processed for immunofluorescence detection of the
Golgi apparatus using an antibody against GM130. The immuno-
fluorescent images were merged with the phase-contrast images
of the fixed cells.
Neoplasia Vol. 11, No. 9, 2009 Calphostin C Induces Endoplasmic Reticulum Stress Kaul and Maltese 831
proteins that have yet to be identified. Finally, we cannot completely
rule out the possibility that ER vacuolization triggered by cal-C is re-
lated to a general increase in cellular ROS [16], which could lead to
protein misfolding in the ER. However, with respect to the latter pos-
sibility, we note that addition of the ROS inhibitor,N -acetylcysteine, at
concentrations as high as 50 mM, did not prevent ER vacuolization
(data not shown).
As noted previously, STS did not mimic the effects of cal-C on ER
vacuolization and stress response. Nevertheless, it was clearly able to
induce caspase 9 activation and apoptosis. Therefore, although the
disruption of ER morphology and protein export by cal-C is proba-
bly due to the inhibition of a non-PKC target, the subsequent apop-
tosis could be related to composite effects of cal-C mediated through
both direct inhibition of PKC and PKC-independent ER stress. We
found that cleavage of procaspase 9 (Figure 7A) occurs very soon after
photoactivation of cal-C, implying early mitochondrial involvement
in the apoptotic response. This could be triggered by the rapid in-
duction of the mitochondrial permeability transition, as noted in pre-
vious studies with STS [53,54]. At the same time, the close temporal
correlation of caspase 9 activation and PARP cleavage with swelling
of the ER and activation of JNK, PERK, and CHOP could support a
model wherein apoptosis induced by cal-C is driven by unmitigated
ER stress. These mechanisms need not be mutually exclusive. In fact,
the probable multifactorial nature of the death pathway induced by
cal-C is supported by our observation that interference with one key
effector of the ER stress response (e.g., CHOP), offered only partial
protection from cell death (Figure 5).
The exact sequence of molecular events that occurs between the
onset of ER stress and the activation of a mitochondrial apoptotic
response remains incompletely understood [55–57]. One possibility
is that apoptosis is mediated by down-regulation of Bcl-2 and Bcl-XL
[58], with concomitant oligomerization of Bax or Bad on the ER or
mitochondria [59]. This scenario would fit with a study in glioma
cells showing that cal-C stimulates rapid integration of Bax into mito-
chondrial membranes, followed by cytochrome c release [36]. The
early spike in activation of JNK in cells treated with cal-C (Figure 4A)
raises a second possibility that mitochondrial injury might be caused
by the ability of JNK to stimulate cleavage of Bid [60] or activation of
other BH3-only Bcl-2 family members such as Bim or Bmf [61].
Finally, it is conceivable that ER stress caused by cal-C could trigger
apoptosis through local activation of an initiator caspase in the ER.
Procaspase 12 has been reported to localize in the ER and undergo
cleavage in response to ER stress in rodent cells [62]. However, a spe-
cific requirement for caspase 12 for subsequent apoptosis remains con-
troversial [38,45,63]. Caspase 12 is truncated or inactive in human
cells [64], and the related caspase 4 has been proposed to function
as an alternate ER stress–sensitive initiator of apoptosis [43,44]. We
did not observe a consistent increase in caspase 4 activation during
the early period when cal-C triggered caspase 9 activation and PARP
cleavage. Thus, it seems unlikely that caspase 4 plays a key role as an
initiator caspase in the apoptotic response induced by cal-C. Caspase 7
is traditionally regarded as an executioner caspase that functions
downstream from proapoptotic signals emanating from the mito-
chondria [40]. However, it has also been proposed to function as an
ER-localized initiator caspase that can respond to ER stress by pro-
moting cleavage of procaspase 12 [42] and, by inference, caspase 4.
We observed the activation of caspase 7 together with activation of
caspase 9 (Figure 7) and cleavage of PARP (Figure 1) within 1 to
2 hours after photoactivation of cal-C, well before increased cleavage
of procaspase 4. This timing would be most consistent with caspase 7
acting as an executioner caspase in concert with activation of caspase 9.
The findings of the present study could have important implica-
tions for the design of new cancer therapeutic strategies aimed at
exploiting the ER stress response. Bortezomib, which causes accumu-
lation of misfolded proteins in the ER by blocking the activity of the
26S proteasome, has already been approved for the treatment of mul-
tiple myeloma and is being evaluated for efficacy against other ma-
lignancies [65–67]. Other ER stress inducers have shown promise in
preclinical trials. For example, 2,5-dimethyl-celecoxib, which is in-
active against cyclooxygenase-2 but causes ER stress by increasing in-
tracellular free calcium [68], has proven to be effective in reducing
the growth and survival of several different types of cancer in cell
culture and animal models [69,70]. In addition to their intrinsic anti-
neoplastic activity, there is some evidence that ER stress inducers
may be useful in potentiating the effects of established therapeutic
agents that trigger cell death through other mechanisms (e.g.,
DNA damage) [71–73]. Most recently, several studies have suggested
that combining different drugs that induce ER stress through distinct
mechanisms may yield synergistic anticancer activity [74–76]. The
results of the present study raise the prospect that cal-C may be a
useful addition to the arsenal of agents that can be applied to pro-
mote death in tumor cells by inducing morphologic and functional
perturbation of the ER or by triggering mitochondrial death path-
ways independent of direct DNA damage. In this respect, cal-C
could offer a unique advantage because its activity depends on photo-
excitation, allowing for the possibility of restricting cytotoxicity to local-
ized tumor sites. We suggest that this concept merits further evaluation
in preclinical studies.
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